AI assistant
MEDIFAST INC — Director's Dealing 2016
Mar 3, 2016
33899_dirs_2016-03-03_0199660a-5de4-41af-ae74-b8dcb5187407.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2016-03-01
Reporting Person: SHEETZ MARGARET (President & COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-03-01 | Common Stock | S | 1362 | $30.72 | Disposed | 342650 | Direct |
| 2016-03-01 | Common Stock | S | 6971 | $30.55 | Disposed | 335679 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6580 | Indirect |
Footnotes
F1: The sales reported in this Form 4 were made pursuant to a 10b5-1 plan adopted by the reporting person on June 9, 2015.
F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.70 to $30.75. The reporting person agrees to provide upon request by the SEC Staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.
F3: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.33 to $30.69. The reporting person agrees to provide upon request by the SEC Staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.